T1	Participants 77 120	patients with breast and colorectal cancer.
T2	Participants 827 918	patients with breast cancer (BRCA) and colorectal cancer (CRC) during adjuvant chemotherapy
T3	Participants 1355 1367	participants
T4	Participants 1093 1105	participants
T5	Participants 1160 1172	participants
T6	Participants 1526 1544	intervention group
T7	Participants 1746 1764	intervention group
T8	Participants 1783 1796	control group
T9	Participants 1969 1987	intervention group
